{"_buckets": {"deposit": "0d7f0c87-5e4f-4e35-bd80-1f9d9826bb35"}, "_deposit": {"created_by": 37, "id": "3029", "owner": "37", "owners": [37], "owners_ext": {"displayname": "", "username": ""}, "pid": {"revision_id": 0, "type": "recid", "value": "3029"}, "status": "published"}, "_oai": {"id": "oai:meral.edu.mm:recid/3029", "sets": ["user-um1"]}, "communities": ["um1"], "item_1583103067471": {"attribute_name": "Title", "attribute_value_mlt": [{"subitem_1551255647225": "Association between HLA-B* 15:02 and carbamazepine induced severe cutaneous adverse drug reactions in Myanmar", "subitem_1551255648112": "en"}]}, "item_1583103085720": {"attribute_name": "Description", "attribute_value_mlt": [{"interim": "Genetic predisposition to carbamazepine (CBZ)-induced Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) had been reported in several Southeast Asian populations, but not in Myanmar. Previous studies had so far reported more than 70% of CBZ-induced SJS/TEN cases\npositive for HLA-B*15:02 allele.1-4 Myanmar, as the second largest country in Southeast Asia with a population of 54.5 million, has high HLA-B*15:02 carrier frequency in its general population (27.3- 49.1%).5,6."}]}, "item_1583103108160": {"attribute_name": "Keywords", "attribute_value_mlt": [{"interim": "Stevens-Johnson syndrome, Toxic epidermal necrolysis, Carbamazepine, HLA-B*15:02, Myanmar"}]}, "item_1583103120197": {"attribute_name": "Files", "attribute_type": "file", "attribute_value_mlt": [{"date": [{"dateType": "Available", "dateValue": "2020-08-24"}], "download_preview_message": "", "file_order": 0, "filename": "Association between HLA-B 15.pdf", "filesize": [{"value": "119 Kb"}], "format": "application/pdf", "future_date_message": "", "is_thumbnail": false, "mimetype": "application/pdf", "size": 119000.0, "url": {"url": "https://meral.edu.mm/record/3029/files/Association between HLA-B 15.pdf"}, "version_id": "d7bed452-b060-46df-8ee0-b9e4b8b75878"}]}, "item_1583103131163": {"attribute_name": "Journal articles", "attribute_value_mlt": [{"subitem_issue": "3", "subitem_journal_title": "Neurology Asia", "subitem_pages": "283-285", "subitem_volume": "22"}]}, "item_1583105942107": {"attribute_name": "Authors", "attribute_value_mlt": [{"subitem_authors": [{"subitem_authors_fullname": "Amy Hui-Ping Khor"}, {"subitem_authors_fullname": "Seinn Mya Mya Aye"}, {"subitem_authors_fullname": "Kheng-Seang Lim"}, {"subitem_authors_fullname": "Yan Lynn Aung"}, {"subitem_authors_fullname": "Yin Minn Aye"}, {"subitem_authors_fullname": "Ohnmar"}, {"subitem_authors_fullname": "Win Min Thit"}, {"subitem_authors_fullname": "Chong-Tin Tan"}, {"subitem_authors_fullname": "Ching-Ching Ng"}]}]}, "item_1583108359239": {"attribute_name": "Upload type", "attribute_value_mlt": [{"interim": "Publication"}]}, "item_1583108428133": {"attribute_name": "Publication type", "attribute_value_mlt": [{"interim": "Journal article"}]}, "item_1583159729339": {"attribute_name": "Publication date", "attribute_value": "2017-12-15"}, "item_title": "Association between HLA-B* 15:02 and carbamazepine induced severe cutaneous adverse drug reactions in Myanmar", "item_type_id": "21", "owner": "37", "path": ["1582963366982", "1597649184558"], "permalink_uri": "http://hdl.handle.net/20.500.12678/0000003029", "pubdate": {"attribute_name": "Deposited date", "attribute_value": "2020-08-24"}, "publish_date": "2020-08-24", "publish_status": "0", "recid": "3029", "relation": {}, "relation_version_is_last": true, "title": ["Association between HLA-B* 15:02 and carbamazepine induced severe cutaneous adverse drug reactions in Myanmar"], "weko_shared_id": -1}